Newsroom

We’re excited to share that Dendrogenix will take part in the upcoming Sambrinvest Bio Investment Convention on October 16, 2025, a key event bringing together innovative companies and forward-thinking investors in the Wallonia region. This convention offers a valuable opportunity for us to showcase our progress in developing next-generation neuroprotective and neuroregenerative therapies in the field of Hearing Loss, and to connect with partners who share our vision for transforming patient care. Our team looks forward to engaging discussions on our clinical and strategic milestones, while exploring new avenues for collaboration and investment to fuel the next stage of our growth.